Cancer cell and Golgi apparatus phospholipid membranes

Cancer cell and Golgi apparatus phospholipid membranes represent a complex structural target rather than a single molecular entity. In malignant cells, the composition of these membranes often shifts, featuring altered levels of specific phospholipids like phosphatidylserine or sphingomyelin, which can be exploited for selective therapeutic intervention. The Golgi apparatus, in particular, serves as a critical hub for protein glycosylation and trafficking; its membrane integrity is essential for maintaining the secretory pathway and cellular homeostasis. Drugs targeting these membranes, such as synthetic alkylphospholipids, work by integrating into the lipid bilayer, disrupting signal transduction, and triggering apoptosis. While promising for overcoming traditional drug resistance, the primary challenge remains achieving sufficient selectivity to avoid damaging the membranes of healthy host cells.

Other names

Cancer cell membranesGolgi apparatus membranesTumor cell phospholipid bilayers

Disruption of membrane integrity, inhibition of phospholipid metabolism, induction of apoptosis via the extrinsic or intrinsic pathways, and interference with Golgi-mediated protein trafficking.